Pannarin inhibits cell growth and induces cell death in human prostate carcinoma DU-145 cells

Anti-Cancer Drugs

Volumn 17, Issue 10, 2006, Pages 1163-1169

  Russo, Alessandra ^a   Piovano, Marisa ^b   Lombardo, Laura ^a   Vanella, Luca ^a   Cardile, Venera ^a   Garbarino, Juan ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b DEPARTAMENTO DE FÍSICA   (Chile)

Author keywords

Apoptosis; Cell growth; DU 145; Human prostate cancer; Lichen metabolites; Necrosis

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; DNA FRAGMENT; EPIPHORELLIC ACID 1; LACTATE DEHYDROGENASE; PANNARIN; PLANT MEDICINAL PRODUCT; REACTIVE OXYGEN METABOLITE; SPHAEROPHORIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL GROWTH; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME RELEASE; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZOATES; BENZOXEPINS; CARCINOMA; CASPASE 3; CELL DEATH; CELL GROWTH PROCESSES; CELL SURVIVAL; DEPSIDES; DNA FRAGMENTATION; HUMANS; L-LACTATE DEHYDROGENASE; LICHENS; MALE; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

EID: 33750566918     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cad.0000236310.66080.ed     Document Type: Article

References (39)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics. CA Cancer J Clin 2004; 54:8-29.
2. Brawley OW, Barnes S, Parnes H. The future of prostate cancer prevention. Ann N Y Acad Sci 2001; 952:145-152.
3. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1:34-45.
4. Rangel C, Matzkin H, Soloway MS. Experience with weekly doxorubicin (adriamycin) in hormone-refractory stage D2 prostate cancer. Urology 1992; 39:577-582.
5. Hussain MH, Pienta KJ, Redman BG, Cummings GD, Flaherty LE. Oral etoposide in the treatment of hormone-refractory prostate cancer. Cancer 1994; 74:100-103.
6. Roth BJ, Yeap BY, Wilding G, Kasimis B, McLeod D, Loehrer PJ. Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the Eastern Cooperative Oncology Group. Cancer 1993; 72:2457-2460.
7. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3:768-780.
8. Cardile V, Scifo C, Russo A, Falsaperla M, Morgia G, Motta M, et al. Involvement of HSP70 in resveratrol-induced apoptosis of human prostate cancer. Anticancer Res 2003; 23:4921-4926.
9. Scifo C, Cardile V, Russo A, Consoli R, Vancheri C, Capasso F, et al. Resveratrol and propolis as necrosis or apoptosis inducers in human prostate carcinoma cells. Oncol Res 2004; 14:415-426.
10. Yim D, Singh RP, Agarwal C, Lee S, Chi H, Agarwal R. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res 2005; 65:1035-1044.
11. Mohanty NK, Saxena S, Singh UP, Goyal NK, Arora RP. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia. Urol Oncol 2005; 23:383-385.
12. Bonham M, Posakony J, Coleman I, Montgomery B, Simon J, Nelson PS. Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma. Clin Cancer Res 2005; 11:3905-3914.
13. Barnes S. Role of phytochemicals in prevention and treatment of prostate cancer. Epidemiol Rev 2001; 23:102-105.
14. Saleem M, Adhami VM, Siddiqui IA, Mukhtar H. Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr Cancer 2003; 47:13-23.
15. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of tomato products, lycopene and prostate cancer risk. J Natl Cancer Inst 2002; 94:391-398.
16. Quilhot W, Garbarino JA, Piovano M, Chamy MC, Gambaro V, Oyarzún ML, et al. Studies on Chilean lichens. XI. Secondary metabolites from Antarctic lichens Ser. Cient. INACH 1989; 39:75-89.
17. Quilhot W, Piovano M, Arancibia H, Garbarino JA, Gambero V. Studies on Chilean lichens XII. Chemotaxonomy of the genus Psoroma. J Nat Prod 1989; 52:191-192.
18. Cardile V, Renis M, Scifo C, Lombardo L, Gulino R, Mancari B, et al. Behaviour of the new asbestos amphibole fluor-edenite in different lung cell systems. Int J Biochem Cell Biol 2004; 36:849-860.
19. Russo A, Cardile V, Lombardo L, Vanella L, Vanella A, Garbarino JA. Antioxidant activity and antiproliferative action of methanolic extract of Geum quellyon Sweet roots in human tumor cell lines. J Ethnopharmacol 2005; 100:323-332.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
21. Singh NP, Tice RR, Stephens RE, Scheneider EL. A microgel electrophoresis technique for the direct quantitation of DNA damage and repair in individual fibroblasts cultured on microscope slides. Mutat Res 1991; 252:289-296.
22. Correchè RE, Carrasco M, Giannini F, Piovano M, Garbarino J, Enriz RD. Cytotoxic screening activity of secondary lichen metabolites. Acta Farm Bonaerense 2002; 21:273-278.
23. Correchè RE, Enriz RD, Piovano M, Garbarino J, Gomez-Lechon MJ. Cytotoxic and apoptotic effects on hepatocytes of secondary metabolites obtained from lichens. ATLA 2004; 32:605-615.
24. Bezivin C, Tomasi S, Rouaud I, Delcros JG, Boustie J. Cytotoxic activity of compounds from the lichen: Cladonia convolute. Planta Med 2004; 70:874-877.
25. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9:459-470.
26. Aruoma OI. Antioxidant action of plant foods: use of oxidative DNA damage as a tool for studying antioxidant efficacy. Free Radical Res 1999; 30:419-427.
27. Godard T, Deslandes E, Lebailly P, Vigreux C, Sichel F, Poul JM, et al. Early detection of staurosporine-induced apoptosis by comet and annexin V assays. Histochem Cell Biol 1999; 112:155-161.
28. Muller K. Pharmaceutically relevant metabolites from lichens. Appl Microbiol Biotechnol 2001; 56:9-16.
29. Huneck S. New results on the chemistry of lichen substances. Fortschr Chem Org Naturst 2001; 81:1-276.
30. Cocchietto M, Skert N, Nimis PL, Sava G. A review on usnic acid, an interesting natural compound. Naturwissenschaften 2002; 89:137-146.
31. Piovano M, Garbarino JA, Giannini FA, Correchè ER, Feresin G, Tapia A, et al. Evaluation of antifungal and antibacterial activities of aromatic metabolites from lichens. Bol Soc Chil Quim 2002; 47:235-240.
32. Hidalgo ME, Fernandez E, Quilhot W, Lissi E. Antioxidant activity of depsides and depsidones. Phytochemistry 1994; 37:1585-1587.
33. Pilat MJ, Kamradt JM, Pienta KJ. Hormone resistance in prostate cancer. Cancer Metastasis Rev 1998-99; 17:373-381.
34. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000; 21:485-495.
35. Denecker G, Vercammen D, Steemans M, Vanden Berghe T, Brouckaert G, Van Loo G, et al. Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ 2001; 8:829-840.
36. Hetts SW. To die or not to die. An overview of apoptosis and its role in disease. JAMA 1998; 279:300-307.
37. Formigli L, Papucci L, Tani A, Schiavone N, Tempestini A, Orlandini GE, et al. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol 2000; 182:41-49.
38. Padjas A, Lesisz D, Lankoff A, Banasik A, Lisowska H, Bakalarz R, et al. Cytogenetic damage in lymphocytes of patients undergoing therapy for small cell lung cancer and ovarian carcinoma. Toxicol Appl Pharmacol 2005; 209:183-191.
39. Branham MT, Nadin SB, Vargas-Roig LM, Ciocca DR. DNA damage induced by paclitaxel and DNA repair capability of peripheral blood lymphocytes as evaluated by the alkaline comet assay. Mutat Res 2004; 560:11-17.